This website is intended to provide informationto an international audience outsie the USA, the UK, Austria ans Southern African coutries including South Africa. If you are a US visitor, please click here .
This website is intended to provide informationto an international audience outsie the USA, the UK, Austria ans Southern African coutries including South Africa. If you are a US visitor, please click here .
Register to gain access to personalised information regarding Brand, the indications your are treating regularly, dosing guidelines and resources such as Major Studies, Patient Information and short videos curated to your special interest.
Xarelto® Indications
Stroke prevention in NVAF
Xarelto is indicated for stroke prevention in adults with non-valvular atrial fibrillation with one or more risk factors1
Prevention of Atherothrombotic Events in Peripheral Artery Disease
Xarelto is indicated for the prevention of atherothrombotic events in adults with symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.
Prevention of Atherothrombotic Events in Chronic Peripheral Artery Disease
Xarelto is indicated for the prevention of atherothrombotic events in adults with symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.
